skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Compositions and methods for adoptive and active immunotherapy

Patent ·
OSTI ID:1117675

Modular aAPCs and methods of their manufacture and use are provided. The modular aAPCs are constructed from polymeric microparticles. The aAPCs include encapsulated cytokines and coupling agents which modularly couple functional elements including T cell receptor activators, co-stimulatory molecules and adhesion molecules to the particle. The ability of these aAPCs to release cytokines in a controlled manner, coupled with their modular nature and ease of ligand attachment, results in an ideal, tunable APC capable of stimulating and expanding primary T cells.

Research Organization:
ORISE (Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States))
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-06OR23100
Assignee:
Yale University (New Haven, CT)
Patent Number(s):
8,629,098
Application Number:
12/812,304
OSTI ID:
1117675
Resource Relation:
Patent File Date: 2009 Jul 30
Country of Publication:
United States
Language:
English

References (74)

Process for encapsulation of medicaments patent June 1976
Polymeric gene delivery system patent September 2003
Tuning tumor-specific T-cell activation: a matter of costimulation? journal May 2002
Controlled-Release Vaccines-Biodegradable Polylactide/Polyglycolide (PL/PG) Microspheres as Antigen Vehicles journal February 1992
Biodegradation and biocompatibility of PLA and PLGA microspheres journal December 2012
Isotypic and allotypic variation of human class II histocompatibility antigen α-chain genes journal March 1984
A New Long-Acting Injectable Microcapsule System for the Administration of Progesterone journal May 1979
New long-acting injectable microcapsule contraceptive system journal October 1979
Characterization of Drug-Loaded Poly(d,l-lactide) Microspheres journal December 1984
An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein journal November 1993
Antigen processing for presentation by MHC class I molecules journal February 1992
Particulate delivery systems for biodefense subunit vaccines journal June 2005
The Influence Of Adjuvant On The Therapeutic Efficacy Of A Recombinant Genital Herpes Vaccine journal November 1994
Co-stimulation in T cell responses journal June 1997
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function journal May 2003
B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells journal March 1997
Adoptive-cell-transfer therapy for the treatment of patients with cancer journal September 2003
Increased TCR Avidity after T Cell Activation journal February 2001
Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting journal October 2005
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. journal March 1995
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells journal June 2005
Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. journal March 1990
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines journal July 1998
Amino acid substitution matrices from protein blocks. journal November 1992
Efficient Presentation of Naturally Processed HLA Class I Peptides by Artificial Antigen-Presenting Cells for the Generation of Effective Antitumor Responses journal May 2006
T cell receptor antagonist peptides induce positive selection journal January 1994
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells book January 2003
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices journal December 2000
Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles journal January 2007
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens journal January 2005
Alloantigen-Induced CD25 + CD4 + Regulatory T Cells Can Develop In Vivo from CD25 CD4 + Precursors in a Thymus-Independent Process journal January 2004
The ABCs of artificial antigen presentation journal March 2004
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes journal June 1988
Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity journal December 1986
New advances in microsphere-based single-dose vaccines journal October 1997
Polymers for the sustained release of proteins and other macromolecules journal October 1976
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells journal April 2000
Antigen presentation: Coming out gracefully journal August 1998
Cd28/B7 System of t cell Costimulation journal April 1996
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection journal January 2002
Antiviral Effect and Ex Vivo CD4+ T Cell Proliferation in HIV-Positive Patients as a Result of CD28 Costimulation journal June 1996
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB journal February 2002
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells journal January 2003
Novel microcapsules for delivery systems journal October 1987
CD28 as a Molecular Amplifier Extending TCR Ligation and Signaling Capabilities journal December 2001
Self-Ignorance in the Peripheral T-Cell Pool journal June 1993
Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope journal February 2002
A general method applicable to the search for similarities in the amino acid sequence of two proteins journal March 1970
Spinning molecular immunology into successful immunotherapy journal April 2002
Artificial antigen-presenting cells as a tool to exploit the immune `synapse' journal December 2000
The Central Effectors of cell Death in the Immune System journal April 1999
Peripheral selection of the T cell repertoire journal March 1991
The Use of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus Induced Lymphoma in Transplant Recipients journal January 2000
Cytokine control of memory T-cell development and survival journal April 2003
A cell culture model for T lymphocyte clonal anergy journal June 1990
Needles in haystacks: identifying specific peptide antigens for T cells journal April 1996
Bispecific antibody: a tool for diagnosis and treatment of disease journal March 1990
A Comprehensive Platform for Ex Vivo T-cell Expansion Based on Biodegradable Polymeric Artificial Antigen-presenting Cells journal April 2008
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy journal April 2009
T-Cell Activation by Soluble MHC Oligomers Can Be Described by a Two-Parameter Binding Model journal November 2001
Multi-epitope DNA vaccines journal August 1997
Dual Function of Drosophila Cells as APCs for Naive CD8+ T Cells: Implications for Tumor Immunotherapy journal June 1996
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. journal December 1998
Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide–class I complexes and recombinant B7–Fc proteins journal March 2001
Exosomes: composition, biogenesis and function journal August 2002
Antigen Recognition by Class I-Restricted T Lymphocytes journal April 1989
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles journal January 2000
Liposomes with Incorporated MHC Class Il/Peptide Complexes as Antigen Presenting Vesicles for Specific T Cell Activation journal January 1999
How LCR Works journal November 1991
Processing of bacterial antigens for peptide presentation on MHC class I molecules journal December 1999
Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins journal May 1985
In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres journal May 1993
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells journal November 2002
Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes book January 1992

Cited By (5)


Similar Records

A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro
Journal Article · Fri Aug 05 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:1117675

Staphylococcal enterotoxin C2 stimulated the maturation of bone marrow derived dendritic cells via TLR-NFκB signaling pathway
Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Experimental Cell Research · OSTI ID:1117675

Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression
Journal Article · Wed Aug 01 00:00:00 EDT 1990 · Journal of Investigative Dermatology; (USA) · OSTI ID:1117675

Related Subjects